CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 123 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.29 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $829 | -95.1% | 55,629 | +898.0% | 0.00% | – |
| Q1 2022 | $17,000 | -65.3% | 5,574 | -50.2% | 0.00% | – |
| Q3 2021 | $49,000 | +2.1% | 11,198 | 0.0% | 0.00% | – |
| Q2 2021 | $48,000 | +152.6% | 11,198 | +163.3% | 0.00% | – |
| Q1 2021 | $19,000 | – | 4,253 | +25.2% | 0.00% | – |
| Q4 2020 | $0 | – | 3,398 | -52.7% | 0.00% | – |
| Q3 2020 | $0 | – | 7,178 | -76.1% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 30,042 | +339.9% | 0.00% | – |
| Q4 2019 | $13,000 | +160.0% | 6,829 | +493.3% | 0.00% | – |
| Q3 2019 | $5,000 | -98.6% | 1,151 | -97.8% | 0.00% | -100.0% |
| Q2 2019 | $369,000 | +442.6% | 51,645 | +903.0% | 0.00% | – |
| Q1 2019 | $68,000 | +58.1% | 5,149 | -6.3% | 0.00% | – |
| Q4 2018 | $43,000 | 0.0% | 5,497 | +40.8% | 0.00% | – |
| Q3 2018 | $43,000 | – | 3,904 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,641,804 | $7,454,000 | 6.54% |
| COMMODORE CAPITAL LP | 2,983,513 | $13,545,000 | 5.40% |
| Foresite Capital Management IV, LLC | 1,787,094 | $8,113,000 | 0.97% |
| Avoro Capital Advisors LLC | 10,300,000 | $46,762,000 | 0.81% |
| Boxer Capital, LLC | 4,000,000 | $18,160,000 | 0.62% |
| Sio Capital Management, LLC | 562,339 | $2,553,000 | 0.52% |
| ACUTA CAPITAL PARTNERS, LLC | 315,341 | $1,432,000 | 0.52% |
| CM Management, LLC | 150,000 | $681,000 | 0.51% |
| APIS CAPITAL ADVISORS, LLC | 120,000 | $545,000 | 0.50% |
| Versant Venture Management, LLC | 543,753 | $2,469,000 | 0.48% |